Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism
Aims/hypothesis: This study aimed to examine if beta-aminoisobutyric acid (BAIBA) is (i) secreted by skeletal muscle in humans during exercise, (ii) associated with insulin secretory function in vivo, and (iii) directly linked with acute glucose-mediated insulin release by pancreatic beta cells in v...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Metabolism Open |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589936820300335 |
id |
doaj-841acbf5f0ba462dae19c286578b2d5e |
---|---|
record_format |
Article |
spelling |
doaj-841acbf5f0ba462dae19c286578b2d5e2020-11-25T01:38:26ZengElsevierMetabolism Open2589-93682020-09-017100053Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolismJonathan P. Barlow0Kristian Karstoft1Andreas Vigelsø2Martin Gram3Jørn W. Helge4Flemming Dela5Kirk Pappan6Donna O’Neil7Warwick Dunn8Thomas P.J. Solomon9School of Sport, Exercise, and Rehabilitation Sciences, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, UK; Mitochondrial Profiling Centre, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, UK; Corresponding author. Mitochondrial Profiling Centre, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, B15 2TT, UK.Centre of Inflammation and Metabolism, Rigshospitalet, Copenhagen, Denmark; Centre for Physical Activity Research, Rigshospitalet, Copenhagen, DenmarkDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Geriatrics, Bispebjerg-Frederiksberg University Hospital, Bispebjerg, DenmarkMetabolon Inc, Durham, NC, USASchool of Biosciences and Phenome Centre Birmingham, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, UKSchool of Biosciences and Phenome Centre Birmingham, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, UK; Institute for Metabolism and Systems Research, College of Medical Sciences, University of Birmingham, Edgbaston, UKSchool of Sport, Exercise, and Rehabilitation Sciences, College of Life and Environmental Sciences, University of Birmingham, Edgbaston, UK; Institute for Metabolism and Systems Research, College of Medical Sciences, University of Birmingham, Edgbaston, UKAims/hypothesis: This study aimed to examine if beta-aminoisobutyric acid (BAIBA) is (i) secreted by skeletal muscle in humans during exercise, (ii) associated with insulin secretory function in vivo, and (iii) directly linked with acute glucose-mediated insulin release by pancreatic beta cells in vitro. Methods: Following 2-weeks of single-leg immobilization, plasma BAIBA concentrations were measured in the brachial artery and the femoral veins of each leg in healthy male subjects, at rest and during two-legged dynamic knee-extensor exercise. During a 2-h hyperglycamic clamp, insulin secretory function and levels of plasma BAIBA were assessed in non-diabetic individuals, non-diabetic individuals following 24-h hyperglycemia and patients with type 2 diabetes. Direct effects of BAIBA on acute glucose-mediated insulin release were probed in INS-1832/3 cells under normal and ‘diabetes-like’ conditions. Finally, the effect of BAIBA on mitochondrial function was assessed in INS-1832/3 cells using extracellular flux analysis. Results: (i) BAIBA is released from skeletal muscle at rest and during exercise under healthy conditions but is suppressed during exercise following leg immobilization, (ii) plasma BAIBA concentrations inversely associate with insulin secretory function in humans, (iii) BAIBA lowers mitochondrial energy metabolism in INS-1 832/3 cells in parallel with decreased insulin secretionConclusion/interpretation: BAIBA is a myokine released by skeletal muscle during exercise and indepedantly alters the triggering pathway of insulin secretion in cultured INS-1832/3 cells.http://www.sciencedirect.com/science/article/pii/S2589936820300335ExerciseMuscle contractionMyokineType 2 diabetesGlucolipotoxicityPancreatic beta-cell |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jonathan P. Barlow Kristian Karstoft Andreas Vigelsø Martin Gram Jørn W. Helge Flemming Dela Kirk Pappan Donna O’Neil Warwick Dunn Thomas P.J. Solomon |
spellingShingle |
Jonathan P. Barlow Kristian Karstoft Andreas Vigelsø Martin Gram Jørn W. Helge Flemming Dela Kirk Pappan Donna O’Neil Warwick Dunn Thomas P.J. Solomon Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism Metabolism Open Exercise Muscle contraction Myokine Type 2 diabetes Glucolipotoxicity Pancreatic beta-cell |
author_facet |
Jonathan P. Barlow Kristian Karstoft Andreas Vigelsø Martin Gram Jørn W. Helge Flemming Dela Kirk Pappan Donna O’Neil Warwick Dunn Thomas P.J. Solomon |
author_sort |
Jonathan P. Barlow |
title |
Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism |
title_short |
Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism |
title_full |
Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism |
title_fullStr |
Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism |
title_full_unstemmed |
Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism |
title_sort |
beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from ins-1 832/3 cells by mediating mitochondrial energy metabolism |
publisher |
Elsevier |
series |
Metabolism Open |
issn |
2589-9368 |
publishDate |
2020-09-01 |
description |
Aims/hypothesis: This study aimed to examine if beta-aminoisobutyric acid (BAIBA) is (i) secreted by skeletal muscle in humans during exercise, (ii) associated with insulin secretory function in vivo, and (iii) directly linked with acute glucose-mediated insulin release by pancreatic beta cells in vitro. Methods: Following 2-weeks of single-leg immobilization, plasma BAIBA concentrations were measured in the brachial artery and the femoral veins of each leg in healthy male subjects, at rest and during two-legged dynamic knee-extensor exercise. During a 2-h hyperglycamic clamp, insulin secretory function and levels of plasma BAIBA were assessed in non-diabetic individuals, non-diabetic individuals following 24-h hyperglycemia and patients with type 2 diabetes. Direct effects of BAIBA on acute glucose-mediated insulin release were probed in INS-1832/3 cells under normal and ‘diabetes-like’ conditions. Finally, the effect of BAIBA on mitochondrial function was assessed in INS-1832/3 cells using extracellular flux analysis. Results: (i) BAIBA is released from skeletal muscle at rest and during exercise under healthy conditions but is suppressed during exercise following leg immobilization, (ii) plasma BAIBA concentrations inversely associate with insulin secretory function in humans, (iii) BAIBA lowers mitochondrial energy metabolism in INS-1 832/3 cells in parallel with decreased insulin secretionConclusion/interpretation: BAIBA is a myokine released by skeletal muscle during exercise and indepedantly alters the triggering pathway of insulin secretion in cultured INS-1832/3 cells. |
topic |
Exercise Muscle contraction Myokine Type 2 diabetes Glucolipotoxicity Pancreatic beta-cell |
url |
http://www.sciencedirect.com/science/article/pii/S2589936820300335 |
work_keys_str_mv |
AT jonathanpbarlow betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT kristiankarstoft betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT andreasvigelsø betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT martingram betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT jørnwhelge betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT flemmingdela betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT kirkpappan betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT donnaoneil betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT warwickdunn betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism AT thomaspjsolomon betaaminoisobutyricacidisreleasedbycontractinghumanskeletalmuscleandlowersinsulinreleasefromins18323cellsbymediatingmitochondrialenergymetabolism |
_version_ |
1725053820185083904 |